What is Hydrocephalus Association?
As a premier non-profit entity, the Hydrocephalus Association serves as a vital nexus for patients, caregivers, and the scientific community. The organization operates at the intersection of medical research and social support, facilitating a comprehensive ecosystem that bridges the gap between clinical diagnosis and long-term quality of life improvements. Through its multifaceted approach—which includes robust educational programming, targeted advocacy, and the direct financing of research—the association maintains a dominant market position in the rare disease advocacy space. Its ability to mobilize resources for treatment advancements has made it an indispensable partner for researchers seeking to translate laboratory findings into tangible patient outcomes.
How much funding has Hydrocephalus Association raised?
Hydrocephalus Association has raised a total of $430K across 2 funding rounds:
Debt
$150K
Debt
$280K
Debt (2020): $150K with participation from PPP
Debt (2021): $280K led by PPP
Key Investors in Hydrocephalus Association
PPP
Public-Private Partnership
What's next for Hydrocephalus Association?
With the recent influx of capital, the Hydrocephalus Association is poised to scale its research funding programs and expand its reach within the global medical community. The strategic deployment of these funds will likely focus on high-impact clinical trials and the development of innovative support infrastructures for those living with the condition. By leveraging this late-stage financial momentum, the organization aims to refine its advocacy efforts, ensuring that the voices of patients are integrated into the broader healthcare policy discourse. Future growth will be defined by the association's capacity to sustain its research pipeline while simultaneously enhancing the accessibility of its support services, thereby cementing its legacy as a leader in neurological health advocacy.
See full Hydrocephalus Association company page
